Louise Nott

645 total citations
10 papers, 132 citations indexed

About

Louise Nott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Louise Nott has authored 10 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Louise Nott's work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Gastric Cancer Management and Outcomes (2 papers). Louise Nott is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Gastric Cancer Management and Outcomes (2 papers). Louise Nott collaborates with scholars based in Australia, Canada and Slovakia. Louise Nott's co-authors include Ken Pittman, Janice Fletcher, Timothy Price, Mark Shackleton, Belinda Yeo, Javier Torres, Michelle Nottage, P. Clingan, Stephanie Snow and George Kannourakis and has published in prestigious journals such as Cancer Research, The Oncologist and Breast Cancer Research and Treatment.

In The Last Decade

Louise Nott

10 papers receiving 128 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louise Nott Australia	6	48	38	34	30	17	10	132
Patricia Bastick Australia	7	110 2.3×	51 1.3×	16 0.5×	28 0.9×	45 2.6×	17	196
M R Narkewicz United States	9	17 0.4×	89 2.3×	20 0.6×	41 1.4×	72 4.2×	24	385
Paul Parker United States	7	39 0.8×	55 1.4×	19 0.6×	23 0.8×	40 2.4×	9	322
Shunji Kawamoto Japan	10	50 1.0×	27 0.7×	19 0.6×	16 0.5×	40 2.4×	34	284
Lilla Lakner Hungary	8	93 1.9×	47 1.2×	8 0.2×	12 0.4×	17 1.0×	14	220
Anne-Sophie Dieudonné Belgium	8	133 2.8×	41 1.1×	5 0.1×	22 0.7×	27 1.6×	11	265
Juan Carlos Cámara Spain	7	103 2.1×	40 1.1×	3 0.1×	20 0.7×	12 0.7×	16	198
Klaus Roelsgaard Denmark	7	51 1.1×	98 2.6×	10 0.3×	6 0.2×	27 1.6×	13	339
Janine Bullard United States	7	35 0.7×	318 8.4×	20 0.6×	47 1.6×	65 3.8×	9	446
Paul de Jong Netherlands	8	39 0.8×	44 1.2×	2 0.1×	10 0.3×	21 1.2×	9	263

Countries citing papers authored by Louise Nott

Since Specialization

Citations

This map shows the geographic impact of Louise Nott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Nott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Nott more than expected).

Fields of papers citing papers by Louise Nott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Nott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Nott. The network helps show where Louise Nott may publish in the future.

Co-authorship network of co-authors of Louise Nott

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Nott. A scholar is included among the top collaborators of Louise Nott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Nott. Louise Nott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Lok, Sheau Wen, Richard de Boer, Laeeq Malik, et al.. (2023). Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. Breast Cancer Research and Treatment. 198(1). 67–74. 7 indexed citations

Wong, Vanessa, Richard de Boer, Sally Baron‐Hay, et al.. (2022). Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer. Clinical Breast Cancer. 22(8). 792–800. 7 indexed citations

Wong, Vanessa, Richard de Boer, Belinda Yeo, et al.. (2022). Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study. Clinical Breast Cancer. 22(7). e764–e772. 1 indexed citations

Antón, A., Rachel Wong, Sheau Wen Lok, et al.. (2021). Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer. Cancer Research. 81(4_Supplement). PS6–35. 1 indexed citations

Thompson, Michael, et al.. (2020). Implementing ‘Goals of Care’ discussion and palliative care referral for patients with advanced lung cancer: an outpatient‐based pilot project. Internal Medicine Journal. 51(4). 540–547. 1 indexed citations

Nott, Louise, et al.. (2020). Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass. Melanoma Research. 30(6). 625–627. 5 indexed citations

Stockler, Martin R., Andrew Martin, Nick Pavlakis, et al.. (2019). Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer. The Oncologist. 24(11). e1102–e1107. 10 indexed citations

Karakiewicz, Pierre I., Louise Nott, Abhishek Joshi, et al.. (2016). Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma. OncoTargets and Therapy. 9. 2855–2855. 3 indexed citations

Michael, Michael, Shane White, Ehtesham Abdi, et al.. (2014). Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC. Asia-Pacific Journal of Clinical Oncology. 11(1). 4–14. 14 indexed citations

10.

Nott, Louise, et al.. (2007). Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy. Leukemia & lymphoma. 48(9). 1702–1711. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact